Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • RhinoMed secures CVS national distribution of new sleep aid product in the U.S
    • News

    RhinoMed secures CVS national distribution of new sleep aid product in the U.S

    Medtech company RhinoMed (ASX: RNO) will soon be significantly increasing its product shelf space in the United States having secured a distribution deal with CVS for its new over-the-counter (OTC) sleep aid product – Pronto Sleep.  With the company forecasting the sleep aids market to reach $66.3 billion by 2021, RhinoMed’s interest focuses on OTC

    Read More
    Public
  • Why free childcare is a hotbed of COVID-19 transmission waiting to kill
    • Opinion

    Why free childcare is a hotbed of COVID-19 transmission waiting to kill

    In the same breath of air, Prime Minister Scott Morrison has stressed practices to prevent the community spread of COVID-19 whilst also encouraging parents to utilise a $1.3 billion stimulus package which will make childcare free. It’s clear that Mr Morrison has no idea how childcare centres function.  At a time when Australia faces an

    Read More
    Public
  • Online transactions surge through COVID-19 lockdowns as Novatti acquires Emersion
    • News

    Online transactions surge through COVID-19 lockdowns as Novatti acquires Emersion

    As society is bunkered down in self-isolation to prevent the spread of COVID-19, fintech company Novatti (ASX: NOV) has acquired payments platform Emersion with both businesses seeing a rise in online payment processing revenue to accommodate the new contact-free world.  The acquisition will see Emersion integrated into Novatti, bringing with it the $1.7m in revenue

    Read More
    Public
  • Opportunistic scammers use coronavirus to spread computervirus
    • News

    Opportunistic scammers use coronavirus to spread computervirus

    Highly publicised tragedies always seem to summon the most despicable of fraudsters. To the rage of many, we saw during the Australian bushfire disaster over 400 fundraiser scams being reported. It appears the coronavirus pandemic is no different, with stories of  phishing emails, fraudulent calls and text messages, and even false claims of vaccine cures.

    Read More
    Public
  • ResApp to launch wireless Sleep Apnoea diagnostics app
    • News

    ResApp to launch wireless Sleep Apnoea diagnostics app

    Australian medtech company ResApp (ASX: RAP) is set to make diagnosing sleep apnoea significantly easier for individuals with the launch of the SleepCheck smartphone app which has been clinically tested.  Obstructive sleep apnoea (OSA) is one of the most common sleep breathing disorders which affects around 30%of men and 20%of women. However, studies show that

    Read More
    Public
  • Microcap solar farm builder MPower secures $4m contract to build another in S.A.
    • News

    Microcap solar farm builder MPower secures $4m contract to build another in S.A.

    Despite trading on the ASX as a microcap, renewable energy company MPower (ASX: MPR) continues to execute a solid pipeline of construction contracts, today announcing the $4 million contract with Astronergy to build a 5MW solar farm in South Australia.  The contract will see MPower execute the engineering, procurement and construction of the solar farm

    Read More
    Public
  • «
  • ‹
  • 619
  • 620
  • 621
  • 622
  • 623
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.